New Insights into the Link Between DNA Damage and Apoptosis

Abstract

Significance: When lesions are unrepaired or there are defects in the DNA repair system, DNA damage is often correlated to apoptosis. However, different kinds of lesions and different degrees of lesion severity can trigger numerous signaling responses. Recent Advances: DNA repair proteins involved in specific DNA repair pathways can modulate the function or activity of some apoptotic factors, further emphasizing the crosstalk between DNA damage and cell death. Critical Issues: Here, we discuss the signaling networks that link DNA damage to apoptosis, and we focus on post-translational modifications, leading to crucial changes in protein behavior, following various kinds of DNA damage. Moreover, we analyze the existence of apoptosis-related functions of typical repair proteins, leading to diverse, often-overlapping, DNA damage responses. Future Directions: The better understanding of the regulation and the functionality of key DNA repair proteins, also involved in apoptosis regulation, has the potential of modulating the cell outcomes on DNA damage, particularly in the context of cancer treatment. Antioxid. Redox Signal. 19, 559–571.

Introduction

T he genome encodes the traits passed from each organism to its descendants: For this reason, the genetic information is extremely precious. Nevertheless, a number of endogenous and environmental stresses constantly threaten genome integrity, thus leading to the evolution of both preventive pathways, such as cell-cycle checkpoints, and efficient DNA repair mechanisms. A successful DNA damage response (DDR) occurs, thanks to a well-orchestrated crosstalk between all these pathways, its relevance to human health being demonstrated by the fact that genomic instability is the cause of many diseases, including cancer (21).

Given the variety of the DNA lesions, different repair mechanisms exist (Fig. 1). In greater detail, the double-strand break repair (DSBR) is deputed to restore the sugar backbone of both DNA filaments after their break (71, 79); the mismatch repair (MMR) principally occurs when the replication and the recombination can cause base–base mismatches and insertion-deletion loops (IDL) (38); the nucleotide excision repair (NER) recognizes bulky, helix-distorting lesions, involving the excision of a single-stranded, lesion-containing oligonucleotide fragment (55); the base excision repair (BER) corrects base lesions arising from oxidation, alkylation, deamination, and depurination/depyrimidination reactions (77); and, finally, the single-strand break repair (SSBR) reconstitutes the sugar backbone of the broken single DNA filament (13).

FIG. 1.

The DNA repair systems. Different DNA lesions activate specific DNA repair pathways: DSBR, MMR, NER, BER, and SSBR. Each repair pathway involves several proteins, as indicated in each box. See text and ref. 13, 38, 55, 71, 77, and 79 for additional details. Proteins indicated in bold (DSBR-related proteins ATM, NBS1, and Ku70/86; MMR-related proteins hMuts and hMutL; MMR-and SSBR-related protein ATR; and NER-related protein DDB2) are also implicated in apoptotic signaling.

The first step for an efficient DNA-damage response is the recognition of the lesion, with this response being mediated by sensor proteins, which specifically recognize the damage and coordinate other molecules (mediators and effectors) that are responsible for the transduction of the signal from the nucleus to the cytoplasm (21, 60). As a result, the cell cycle is arrested, in order to avoid lesion inheritance. In the meantime, DNA-repair mechanisms set about healing the damage. However, if the genome integrity is irreparably compromised, the cell is forced to die. Indeed, when the DNA damage is too severe, cells can undergo permanent cell-cycle arrest (senescence) or cell death (apoptosis/necrosis). Despite the well-established link between unsustainable DNA-damage and induced cell death, the molecular mechanisms responsible for this crosstalk are largely unknown.

In this review, we will focus on the various DDRs and on their link to the apoptotic pathway, emphasizing the role of some proteins as both key players in DNA repair and direct mediators of the apoptotic response, such as Ku. In addition, particular attention has been paid to novel mechanisms that are responsible for cell fate determination on DNA damage, such as the oscillatory activation of p53, the proteasomal degradation, and the redox-mediated regulation of apoptotic and DDR proteins.

DSBR: The p53 Signaling Network and Apoptotic Functions of Repair Proteins

DNA double-strand breaks (DSBs) are among the most serious and lethal types of DNA damage; they can be induced by ionizing radiation, chemical agents, reactive oxygen species (ROS), or as by-products of DNA replication. In fact, during replication, collapsing replication forks leave the DNA backbone broken on a single strand (SSB) that can be often converted to double-strand damage (DSB) (10). The cell has evolved two types of DNA DSBs' repair: homologous recombination (HR) and nonhomologous end joining (NHEJ), on the basis of different fidelity and template requirements (71). HR needs the sister chromatid as a DNA template to repair the break and reconstitute the original sequence, and, for this reason, it occurs during the late S and G2/M phase of the cell cycle (34, 51). It involves several proteins that accumulate at the DNA ends, including the nucleases C-terminal binding protein interacting protein (CtIP)/exonuclease 1 (Exo1) and the Rad51 recombinase complex formed by breast cancer 1 and 2 (BRCA1/2), Rad51/52, Xrcc2/3 (Fig. 1) (34). On the other hand, NHEJ can be activated either in G0/G1 phase or throughout the cell cycle (51). The latter can repair DSBs by preserving the phosphodiester backbone and the molecular integrity of the chromosome without restoring the sequence information in the DNA (44). The formation of the DNA-protein kinase (PK) complex, by the interaction between the catalytic subunit of the DNA-PK (DNA-PKcs) and Ku, is the fundamental step involved in order to activate the DNA repair by NHEJ (Fig. 1) (44). However, in both DSBR pathways, DSB recognition is the first step that is mediated by the Mre11/Rad50/NBS1 (MRN) complex composed of meiotic recombination 11 (Mre11), Rad50, and Nijmegen breakage syndrome 1 (NBS1) (17). Both Mre11, which exhibits exo- and endonuclease activity, and Rad50 have DNA-binding capabilities; while NBS1 is responsible for shuttling the MRN complex to the nucleus. The MRN complex is important for recruiting ataxia telangiectasia mutated (ATM) or ATR (ATM- and Rad3-related) proteins, members of phosphatidylinositol-3 kinase (PI3K) family, which activate a signaling process that leads to cell-cycle checkpoints and pauses cell-cycle progression (35). Two crucial substrates of ATM and ATR are checkpoint 1 and 2 kinases (Chk1 and Chk2), respectively: Once phosphorylated, these are able to induce cell-cycle arrest, thus guaranteeing time for damaged cells to repair their DNA (35). However, the ATR/Chk1-related signaling pathway is principally activated under SSBs, as will be discussed later.

Another initial step for the DSBR is the ATM phosphorylation of the histone H2AX in the vicinity of DSBs, leading to the formation of γH2AX foci (12). These foci act as a signal to recruit other repair proteins in order to allow the assembly of DSBR complexes (42). H2AX phosphorylation can also be mediated by the DNA-PK, the kinase complex that is formed once the NHEJ pathway of DSBR is activated and which acts both as sensor and as effector of DSBR (65).

It is worth noting that mutations of some DSBR genes have been shown to be associated with human syndromes or diseases (9). Among them, mutations of BRCA1 and 2 have been found in several breast and ovarian cancers, whereas mutations of ATM and some components of MRN complex, such as Mre11 and NBS1, have been identified as being associated with ataxia telangiectasia and NBS, as well as in cerebellar atrophy, microcephaly, radiosensitivity, and marked predisposition to cancer. These lines of evidence strongly suggest that these proteins play a crucial role in maintaining genomic integrity.

p53 at the crossroad between DNA damage and apoptosis

All the signaling pathways triggered by DSBs converge on the tumor suppressor p53 (59). p53 can be activated by all the sensor kinases already mentioned (ATM, ATR, DNA-PK, and Chk1/2) that lead to p53 stabilization and accumulation in the nucleus, where it functions as a transcription factor (Fig. 2) (59, 80). In particular, Ser15 and Ser20 of p53 are highly phosphorylated by ATM and Chk2, thus resulting in the dissociation of MDM2, a p53-negative regulator (15, 19, 62). By being modified in this way, p53 escapes proteasomal degradation and enables the activation of its target genes involved in DNA repair (e.g., damaged-DNA binding protein 2 [DDB2], XPC), in cell-cycle arrest (e.g., p21, GADD45α, and 14-3-3σ), and in apoptosis (e.g., Bcl-2-associated X (Bax), Bcl-2 homologous antagonist killer [Bak], p53 up-regulated modulator of apoptosis [Puma], Noxa, and apoptotic protease activating factor 1 [Apaf1]) (74). Moreover, recent findings demonstrate that, on DNA damage, p53 can activate some pro-autophagic genes, such as AMP-activated protein kinase subunits β1 and β2 (AMPK-β1/2), tuberous sclerosis protein 2 (TSC2), phosphatase and tensin holomog (PTEN), damage-regulated autophagy modulator (DRAM), sestrin1 and 2 (Sesn1/2), and Unc-51-like kinase 1 (ULK1) (11, 23, 29, 31).

FIG. 2.

p53 activation on DSBs. DSBs leads to the activation of ATM and Chk2 kinases, which, in turn, activate p53 to induce the expression of several genes, such as those involved in DNA repair, in apoptosis, and, also, two p53 key inhibitors, Wip1 and MDM2. If the DNA damage is sustainable, p53 is promptly inhibited through MDM2 and direct/undirect-Wip1 negative feedback loops, resulting in DNA repair and cell survival. If the DNA is persistently lesioned, continuing ATM/p53 activation allows the accumulation of apoptotic proteins, thus triggering cell death. (To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars.)

As demonstrated by the induction of these genes, p53 activates different signaling pathways that can result in an opposite destiny for the cell. Within a short timeframe after the insult, apoptosis is avoided, thus making it possible to repair the damage. In this context, p53-mediated activation of autophagy could be functional to the energy production that is necessary for DNA repair processes, thus contributing to the pro-survival phase of the DDR. On the other hand, if the lesions accumulate, they are not compatible with the cell life, thus triggering cell death. Once p53 is activated, how can it discriminate between these two opposite scenarios? A p53-negative feedback loop could be the right answer. Active p53 can induce the transcription of its negative modulator MDM2, which has been demonstrated as being crucial in the dynamical behavior of p53 regulation on DNA-damage response (33, 43). Indeed, Batchelor et al. have shown that gamma radiation-induced DNA damage initiates a series of ATM and p53 activation pulses, consisting of p53 activation followed by its subsequent down-regulation (6). As indicated in Figure 2, p53, once phosphorylated by ATM, induces the transcription of its target genes, among them being DNA repair genes and two p53 key inhibitors, MDM2 and wild-type p53-induced phosphatase 1 (Wip1) (6). Both can directly block p53 activity, but Wip1, by dephosphorylating ATM and Chk2, can also inhibit the upstream signal of p53. These two negative feedback loops seem to underlie the regulation of ATM/p53 activation pulses. If the DNA damage is successfully repaired, ATM and p53 are no longer activated and the cell viability is preserved. If the DNA repair is unsuccessful, a round of ATM recruitment at DSBs starts again, with the subsequent activation of ATM and p53 (Fig. 2) (6). These continuous activation pulses of ATM/p53 can lead to the accumulation of several p53 targets which, on the basis of their mRNA and/or protein stability, can display themselves as a dynamic expression pattern (4). Once pro-apoptotic proteins become excessive, they prove fatal to the cell. Moreover, changes in the post-translation modification profile of p53 after its initial activation could act as a molecular barcode and direct the cell toward a specific cellular response (4, 83). In this context, it has been demonstrated that crucial acetylations and methylations at the p53 C-terminal region are essential for its activation as a transcription factor. As a result, different tolerance of p53 on transient or sustained DNA damage has been reported (49).

For the full comprehension of p53's role on DNA damage, its transcriptional-independent function should be also considered. Cytosolic p53 induces cell death by directly acting on mitochondria and favoring the release of pro-apoptotic proteins (32). In addition, it has been demonstrated that p53 has two opposite roles in autophagy regulation, depending on its sub-cellular localization (50). As discussed earlier, nuclear p53 acts as a pro-autophagic factor that induces some autophagy genes; by contrast, the cytosolic pool of p53 is implicated in the inhibition of autophagy (50). Thus, the existence of a p53-mediated interplay between apoptosis and autophagy could, hypothetically, be a response to DDR, accounting for different cellular outcomes.

In addition to the signaling network showing p53 as the major player of the crosstalk between DNA damage and apoptosis, some proteins, commonly involved in DSBR, are also implicated in mediating apoptotic signals.

Ku

The DNA repair complex Ku, comprising Ku70 and Ku86 subunits, is specifically involved in direct binding to the two broken DNA ends (Fig. 3), thus protecting them from excessive degradation, and in the promotion of the NHEJ by the formation of the DNA-PK complex (25, 44). However, Ku has also been demonstrated as being directly linked to the apoptotic signaling pathway that is activated on DNA damage (Fig. 3). It has been shown that Ku can regulate the expression of Apaf1, a pro-apoptotic protein which is fundamental for the execution of the mitochondrial apoptotic pathway (26). Ku-mediated Apaf1 regulation is dynamically modulated on DNA damage: As soon as DNA is damaged, Ku protects cells from apoptosis by blocking Apaf1 transcription; when the DNA damage accumulates highly inside the cells, Ku leaves the Apaf1 promoter, thereby contributing both to the up-regulation of its expression and to the occurrence of apoptosis. Furthermore, the subunit Ku70 has been found to be implicated in regulating Bax translocation into the mitochondria through its direct interaction with Bax and, therefore, in mediating the intrinsic pathway of apoptosis (Fig. 3) (2, 22, 69). Ku70/Bax interaction has been shown to be dependent on Ku70 acetylation status: After apoptotic stimuli, the acetyltransferases CREB-binding protein (CBP) and P300/CBP-associated factor (PCAF) acetylate specific lysine residues on Ku70, thereby resulting in a conformational change of Ku70 and in Bax release (22, 69). Moreover, the stabilization of FLICE-inhibitory protein (FLIP), a well-known inhibitor of death receptor-mediated apoptosis, has recently been reported to be regulated by the subunit Ku70 of the DNA repair complex Ku (Fig. 3) (41). This novel interaction, dependent on Ku70-acetylation status, enables FLIP to interact with the death-inducing signaling complex (DISC) and, thereby, to inhibit the activation of the extrinsic pathway of apoptosis. In addition, the DNA-binding activity of Ku has been found to be abolished on Ku70 acetylation in the DNA-binding domains, thus leading to its decreased capability in DSBs repairing (20). It could be hypothesized that the acetylation status of Ku70 should be properly regulated in order to direct the cell toward apoptosis. Acetylated Ku70 would diminish its ability to repair DNA damage and, simultaneously, to bind Bax and/or FLIP in order to prepare the cell for death. In this scenario, the specific post-translational modification of Ku70 could account for both its dual functions, in DNA repair and in suppressing Bax-mediated apoptosis, and decide the cell fate in a condition of severe DNA damage. Moreover, it is worth mentioning that Liu et al. have demonstrated that, on DNA damage induced by kainic acid, Ku70 is phosphorylated by DNA-PKcs, resulting in Bax release and translocation into the mitochondria to initiate apoptosis (46). There is further evidence highlighting Ku's involvement in the crosstalk between the DNA repair machinery and the DNA damage signaling regulators controlling apoptosis. In particular, it has been recently demonstrated that, on DNA damage, the Ku70 vWA domain (within the N-terminal region) affects activating transcription factor 2 (ATF2)-dependent transcriptional pathway, which modulates several genes implicated in the activation of apoptosis (28). All these findings highlight a crucial role of Ku in regulating the DSBR, acting as its effector, via both its involvement in repair DNA broken termini and its modulation of the mitochondrial apoptotic pathway.

FIG. 3.

Ku involvement in the DSBR pathway and apoptosis. Once DNA damage occurs, Ku binds to DSBs, thus promoting NHEJ. Ku-mediated repression of the Apaf1-promoter is modulated by the level of DNA damage, leading to cell survival or death. Independently of this, cytosolic Ku70 binding to Bax and/or FLIP is correlated to the Ku70-acetylation status and protects the cell. On apoptotic stimuli, acetylated Ku70 releases Bax and/or FLIP, the one re-localizing into the mitochondria and the other being degraded via the proteasome, thus leading to apoptosis. (To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars.)

Nijmegen breakage syndrome 1

NBS1 is a key regulator of DSBR, as it is a component of the MNR complex, the sensor of DSBs, and the activator of ATM (17). It has been reported that NBS1 can also activate Bax and induce apoptosis on DNA damage (36). In particular, Iijimaa et al. have demonstrated a direct association of NBS1 with DNA damage-induced apoptosis, as NBS1 directly interacts with Ku70, allowing Ku70 acetylation and Bax translocation to the mitochondria (36). Petrini's group also discovered that NBS1 C-terminal domain is necessary for apoptosis induction on ionizing radiations (68). In fact, its deficiency interferes with ATM activity by preventing the ATM-mediated phosphorylation of structural maintenance of chromosomes protein (SMC1) and BH3 interacting domain death agonist (Bid) protein (40, 68). It is worth noting that after ionizing radiations, NBS1 C-terminus-depleted mice displayed a severe apoptotic defect without pro-apoptotic genes induction being impaired due to the normal transcriptional activity of p53 (68). Thus, it can be speculated that NBS1 acts at different steps of the DDR: either as a sensor of DSBs or as an effector of DSBs, by activating the apoptotic pathway.

MMR: Direct or Indirect Correlation to the Apoptotic Signaling?

When the cell is in the S-phase of the cell cycle, base–base mismatches can be caused by errors of DNA polymerases, yet have to be removed in order to ensure a correct transmission of genetic information to daughter cells. In addition, microsatellites, which are repeated-sequence motifs within DNA, frequently undergo several mismatches, called IDLs, due to re-annealing incorrectly after DNA synthesis. The MMR is deputed to remove these mispairs, and this involves different proteins: hMSH2 and hMSH6 (human MutS Homologous 2 and 6), which recognize the site of mismatch and, in a form of heterodimer (MutSα), monitor newly synthesized DNA for mispairs (38). hMLH1 and hPMS2, in the form of the MutL heterodimer, interact with MutS at the site of a mismatch (38). Of note, mutations in MMR genes are linked to several cancer types, such as hereditary nonpolyposis colorectal cancer (or Lynch syndrome) (21), further underlining the tight link between alteration of DDR and cancerogenesis.

When MMR is “futile”

Methylating agents, such as N-methyl-N’-nitro-N-nitrosoguanidine, can induce DNA damage repaired by MMR (60). Among different DNA lesions produced by such a methylating agent, there is the methylation of guanine at the O⁶ -position in G-C base pairs. In this context, a well-established theory explaining the link between the MMR and the activation of cell-cycle checkpoints and apoptosis is “the futile cycle model” (Fig. 4) (73). According to this model, during DNA synthesis in the S-phase, O⁶ -meG mispairs with thymine, thus constituting a substrate for MMR, which excises thymine (Fig. 4). However, since O⁶ -meG is still present in the DNA, thymine is reinserted during DNA re-synthesis, thus leading to the futile removal and re-insertion of thymine, and to the formation of DSBs (Fig. 4) (60, 73). In this scenario, both G2 arrest and lethality responses are dependent on DSBR and independent of MMR. Recently, Quiros and collegues have demonstrated that the processing of O⁶ -meG into DSBs requires two rounds of replication and that only in the consequent cell cycles can apoptosis occur (58). MMR still functions solely as DNA repair, by detecting DNA lesions and creating DSBs due to futile cycles of repair or repair-replication fork collision. If the DSBs are not repaired by HR, the cells die by ATR/Chk1-dependent apoptosis (58).

FIG. 4.

The futile cycle of MMR. MMNG modification of guanine (O ⁶-meG) generates a mismatch within DNA (O ⁶-meG/C). During DNA replication, this can be repaired by the MMR pathway with the removal of a cytosine (C) and the insertion of a tymine (T). The new mispair O ⁶-meG/T is still recognized by MMR proteins and leads to a continuous excision/insertion of the tymine during the following replication cycles, thus producing DSBs.

MMR proteins as signaling molecules in DDR

It has been postulated that the signaling cascade of cell-cycle arrest and apoptosis could be also activated by the direct interaction of the damage-bound MMR proteins: hMutSα and hMutLα, with proteins of the ATR-Chk1 pathway. In greater detail, ATR, Chk1, and the Chk1 activator Claspin have been identified as hMutSα-binding partners (Fig. 5) (47, 81). In this scenario, MMR acts as a DNA damage sensor by directly signaling G2 arrest and cell death. This represents “the direct signaling model,” which proposes MMR as having two different functions in DDR: DNA repair and signal transduction.

FIG. 5.

MMR proteins are involved in DDR. When mispairs occur, the MMR proteins can directly activate the apoptotic signaling through the interaction between the DNA binding MutSα/MutLα and the ATR/Chk1 signaling proteins (Chk1, Claspin, ATR/ATRIP); or through transcription factor p73 interaction with PMS2. In addition, the indirect or direct MMR proteins-mediated activation of MAPO/FLCN/AMPK complex results in apoptosis induction. (To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars.)

PMS2, another MMR protein, has been demonstrated as interacting with proteins regulating apoptosis, highlighting other possibilities in the crosstalk between DDR of MMR and apoptosis. The subunit of MutL heterodimer PMS2 is required for cisplatin-induced activation of p73 (Fig. 5) (63). p73 is a member of the p53 family of transcription factors with proapoptotic activity (56). Shimodaira and coworkers have demonstrated that PMS2 specifically interacts with p73, causing its stabilization, and that exposure to cisplatin enhances the association between PMS2 and p73. Many years later, it was also shown that the polymorphic variant of PMS2 (R20Q) is defective in activating p73-dependent apoptotic response to cisplatin, thus contributing to the modulation of tumor responses to cisplatin in cancer patients (52). These results suggest that PMS2 contributes to genome integrity not only through DNA repair but also by directly contributing to the activation of apoptosis. In addition, Lim and colleagues recently demonstrated that a multiprotein complex, comprising MAPO1, folliculin (FLCN), and AMPK, is responsible for apoptosis induction on base-mispairing (Fig. 5) (45). When base-mispairing occurs, activated AMPK levels gradually increase in an MAPO-dependent manner, and such activation correlates with induced cell death. In this context, the molecules responsible for the delivery of the signal from the DNA lesion to the pro-apoptotic complex are still unknown. A direct interaction between the MMR-components and AMPK-MAPO1-FLCN could be supposed, although mass-spectrometry experiments do not provide any evidence that supports this hypothesis.

Furthermore, AMPK activation has previously been correlated to both apoptosis and autophagy induction (16). For this reason, a role for autophagy as a stress response on DNA damage has also to be taken into account. In the light of this evidence, Lim's work allows us to speculate that phosphorylated AMPK could be considered the key molecule triggering autophagy flux in this scenario (45).

NER: When a Repair Protein Functions Twice

The NER is able to repair a wide range of DNA lesions, such as pyrimidine dimers and 6-4 photoproducts produced on UV lights, intra-strand crosslinks, DNA-protein crosslinks, and some DNA adducts caused by oxidative damage (55). The NER machinery involves two sub-pathways: the global genome NER (GG-NER) and the transcription coupled NER (TCR). GG-NER recognizes and removes lesions throughout the entire genome, while TCR is a repair system occurring in parallel to transcription (30). Transcriptional inhibition has a pro-apoptotic effect per se, as genes essential for life are no longer transcribed. In this context, a defect in NER is responsible for impaired gene expression and results in triggering apoptosis (48). Otherwise, defective TCR correlates with nonrepaired lesions, which possibly cause DNA breaks. For this reason, to what extent gene expression blockade is relevant to apoptosis induced by impaired NER/TCR is still a matter for debate.

The dual role of DDB2

A more direct effect of NER components on apoptosis induction is mediated by DDB2. DDB2 is a component of the NER machinery that is responsible for the recognition of UV-damaged DNA. More recently, Bagchi's group characterized DDB2 as an adapter protein of the Cul4 (Cullin4) E3 ligase complex, implicated in ubiquitin-mediated proteasomal degradation (66, 67). Remarkably, the association of DDB2 to Cul4 plays a role in the proteasome targeting of the Cullin-substrate p21 and p53 (Fig. 6). On DNA-damage, p53 is phosphorylated at the Ser15 by the activated ATM/ATR; as a result, its transcriptional activity is enhanced and the expression of its target-gene p21 is increased. In this context, DDB2 counteracts p53 activation by allowing selective delivery of phosphor-Ser15 p53 to the proteasome, thus abolishing p21 up-regulation. In addition to the indirect regulation of p21 transcription, DDB2-Cul4 complex targets p21 protein for ubiquitylation and proteolysis in cells affected by DNA damage. In this context, NER can take place and efficiently repair DNA damage, thus sparing a cell's life. This scenario demonstrates DDB2 function on low-dose UV irradiation (Fig. 6), when the genome integrity is not irreversibly compromised. On the other hand, the negative regulation that DDB2 exerts on p53 is disrupted when high-dose UV irradiation affects the cell, probably due to a post-translational modification occurring in the N-terminal region of p53 and preventing DDB2-mediated degradation (Fig. 6). In this case, p53 is fully active and p21 expression is further increased. p21 up-regulation on DNA damage inhibits the apoptotic pathway, acting as a pro-survival signal for the cell and allowing the damage to be repaired. Despite this, if DNA damage is over-extended, apoptosis is hopefully induced: At this point, p21 down-regulation is required, without affecting global p53 activity. The mechanism coupling these two effects is the DDB2-Cul4 mediated ubiquitylation and consequent degradation of p21 which still occurs on high-dose UV irradiation (Fig. 6) (66, 67). Therefore, the DDB2-dependent mechanism specifically points to the crosstalk between NER-mediated DDR and apoptosis. Of note, a recent characterization of the autophagy interactome has revealed an involvement for Cul4, the DDB2-associated E3 ligase, in the autophagy pathway (7). An investigation of Cul4-mediated switch between apoptosis and autophagy on DNA damage could therefore be of utmost interest.

FIG. 6.

NER-related protein DDB2 in mediating DDR. On UV-induced DNA damage, the p53-mediated signaling pathway is activated. The NER protein DDB2 contributes to cell survival by the proteasome targeting of p53 and p21 in conditions of low UV-dose-induced DNA damage. When the DNA is severely damaged (high UV doses), DDB2 only affects p21 degradation, thereby allowing p53 accumulation and the transcription of p53 apoptotic targets, thus promoting apoptosis. (To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars.)

Base Excision and SSBR: Chk1 Opposite Effects on Apoptosis

BER is a multistep DNA-repair mechanism whose intermediates are potentially dangerous for the cell. It is characterized by the removal of one nucleotide or 2–13 nucleotides and uses the other strand as a template to repair the specific lesion (77). During BER, both AP (apurinic/apyrimidinic site) sites and SSB occur and can cause more severe DNA damage, if they are stalled, because of a defective repair (60). These DNA lesions can be replication-dependent or -independent. In nonreplicating cells, unsolved SSBs occurring on partially overlapping DNA strands result in the formation of DSBs, which, if accumulated, are not compatible with cell life. Moreover, during DNA synthesis, AP sites and SSBs constitute an obstacle for the replication fork, which is blocked and can collapse, leading to DSBs. SSB is always integrated in the BER pathway or can occur in the absence of BER; for instance, when the hydroxyl radical attacks and directly breaks the sugar-phosphate DNA backbone, without creating a base damage.

The ATR/Chk1 signaling pathway

The well-established ATR/Chk1 signaling pathway links the repair system SSBR to apoptosis (54). In particular, the sensor of DNA replication stress is the ssDNA-binding protein replication protein A (RPA), which tightly binds the ssDNA and functions as a platform activating the ATR signaling pathway (24). The ATR/ATR interacting protein (ATRIP) complex is formed within RPA-coated ssDNA regions and is deputed to recruit several factors in order to induce the DNA replication responses, and, in the case of collapsed replication forks, to activate cell-cycle arrest or apoptosis (54). It is worth noting that, during DNA replication stress, the ATR/Chk1 signaling pathway plays a role in preventing apoptosis, because it is directed at the stabilization of DNA replication after stress (24). In particular, two ATR/Chk1 pathways can be activated on different DNA replication stressors: In the context of ionizing radiations, Chk1 blocks a caspase-2-mediated apoptotic response independently of p53 (64); while the ATR/Chk1-mediated suppression of the caspase-3-dependent pathway is activated by replication inhibitors (53). This increases the complexity of the DNA damage apoptotic response, which can involve several signaling pathways depending on the specific forms of DNA damage. Indeed, ATR and Chk1 can also phosphorylate p53, the central downstream checkpoint signaling protein that is responsible for apoptotic responses, as mentioned earlier. In the case of UV-light-mediated SSB generation, a divergent mode of activation from that discovered on gamma-radiation-induced DSBs has been demonstrated (Fig. 7) (5). Indeed, Batchelor et al. have postulated that p53 is activated by a single continuous pulse which is dependent on UV doses, rather than by ATM/p53 no-dose dependent repeated oscillations (5,6). They explain this opposite p53 behavior by the fact that ATM/p53 inhibitor Wip1 is switched off and, thus, cannot contribute toward regulating p53 activation in a pulsatile fashion. Moreover, ATR is not able to induce a rapid MDM2 degradation as ATM does. Taken together, these results involve the same central molecule p53, as it plays a key role in the transcriptional activation of cell cycle and apoptotic proteins. Simultaneously, they also represent an interesting example of how different inputs (UV or gamma radiations) converge to a single molecule (p53) that can display different behaviors depending on the surrounding proteome and, thus, producing different cellular outcomes (Fig. 7). In this context, recent findings from Lahav's group have shown that a switch from pulsed to sustained p53 determines the accumulation of different target genes and, thus, different cellular responses (57). For the first time, it has been demonstrated that p53 dynamics can by themselves control the cell's fate, through a different dynamic induction of cell cycle, apoptosis, senescence, and p53 regulators (57). Moreover, in their study, Purvis et al. manipulated p53 pulses with a sequence of precisely timed drug additions, suggesting that such perturbation of p53 dynamics could constitute a new pharmacological strategy dictating cell fate in a range of diseases (57). However, future studies are necessary to understand how these signaling dynamics are regulated and how they affect cellular outcomes in physiological conditions.

FIG. 7.

p53 responses in different DNA lesions. Both IR-induced DSBs and UV-induced SSBs can activate the central molecule p53, via ATM- or ATR-mediated phosphorylation, respectively. Both these types of DNA damage can produce a different surrounding activated proteome, resulting in two modes of p53 activation: pulsed or sustained. Pulsed and sustained behaviors of p53 lead to the induction of different classes of genes and, thus, to different cellular outcomes.

Redox Implications in DNA Damage

As frequently mentioned earlier, oxidative stress is among the primary inducers of DNA damage. Indeed, ROS, along with nitric oxide (NO)-derived radicals, the so-called reactive nitrogen species (RNS), can react with DNA and produce different DNA lesions (Fig. 8). Moreover, in addition to this direct action, ROS and RNS can oxidize proteins belonging to the DDR system, thereby causing DNA damage indirectly (Fig. 8). ROS and RNS cause structural alterations in DNA, ranging from point mutations to wide chromosomal alterations. These effects are included among those underlying the cell death response. However, it should be remembered that the same effects have been shown to be involved in the induction of neoplastic transformation, thus allowing expression of the mutated phenotype (18). Many environmental insults (e.g., ionizing radiations) have been shown to produce ROS and affect DNA integrity; however, nitroxidative DNA damage also appears to occur naturally, as low steady-state levels of base damage products have been detected in nuclear DNA (1). Indeed, mitochondria and several cellular enzymes can produce ROS and RNS: (i) as by-products of redox reactions that are required for the physiological functions of the cell, (e.g., ATP synthesis or xenobiotics detoxification); (ii) as useful products, whose toxicity is leveraged for whole organism survival (e.g., inflammatory response). Both these events underlie the increased DNA damage observed during ageing and in chronic inflammatory diseases.

FIG. 8.

Redox state effect on DNA damage. Oxidative/nitrosative stress can affect DDR either by directly producing several DNA lesions, involving different DNA repair pathways, or by modifying key repair proteins with the result of DNA-binding decrease. Here, we illustrate some examples: the S-glutathionylation of p53, the oxidation of Ku70/86, and the S-nitrosylation of AGT. Both ROS/RNS-mediated DNA damage and redox-mediated inhibition of DDR proteins can cause structural alterations in DNA, which, if unrepaired, lead to the generation of mutations and/or apoptosis. (To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars.)

Direct oxidative damage

The principal DNA damaging ROS is the hydroxyl radical (OH^•), although other members, such as peroxyl and alkoxyl radicals (RO₂ ^• and RO^•, respectively), peroxynitrite (ONOO⁻), and ozone (O₃), are effective as well (78). Conversely, hydrogen peroxide (H₂O₂) and superoxide radical (O₂ ^•−) have not been documented as significantly affecting DNA stability. ROS generate a plethora of by-products: oxidized bases, the most common of which is 8-hydroxyguanine (8-OHG); abasic sites; DNA–DNA intrastrand adducts; DNA strand breaks; and DNA–protein cross-links (14). All these lesions can trigger the DDR involving the DNA damage repair systems previously discussed.

Redox-mediated inhibition of DDR proteins

Nitroxidative stress has been carefully demonstrated as reversibly modifying proteins at the levels of reactive cysteines. Owing to their low pK_a, these residues are also present as thiolate anions at physiological pH and can easily undergo a reaction with ROS and RNS, as well as with glutathione, thereby generating S-hydroxylated, S-nitrosylated, and S-glutathionylated derivatives, respectively (27). Generally, cysteine redox modifications result in a loss of function of protein activity; this effect has also been demonstrated for some of the proteins involved in DDR, thereby indirectly contributing to the establishment of DNA damage (Fig. 8). Here, we report the most representative examples of proteins required for repairing DNA lesions and whose activity has also been reported as being subjected to redox regulation.

p53

p53 has been reported to have about 10 redox-sensitive cysteine residues undergoing alkylation with N-ethylmaleimide (61). Among them, Cys182 has been suggested as undergoing S-hydroxylation, S-glutathionylation, and disulfide bond formation with Cys227, which are oxidative modifications that contribute to decreased p53 tetramerization, DNA affinity, and gene transcription (70). Moreover, Velu et al. demonstrated that Cys124 and, above all, Cys141, both located in the proximity of the DNA-binding domain of p53, are selectively S-glutathionylated, thus causing inhibition of the domain's DNA-binding activity and dimerization (Fig. 8) (72). S-glutathionylation of Cys141 of p53 could have deep consequences in oncogenesis, as reported in recent correlative studies which show that several cancer tissue and tumor histotypes known to produce ROS, to a great extent, exhibit high levels of S-glutathionylated p53 (82).

Ku

Ku has also been shown to undergo cysteine oxidation-dependent conformational change and reduced DNA binding activity (Fig. 8) (3). However, only a minor role for Cys483 of the Ku86 subunit has been hypothesized, leaving doubts as to the precise residue governing such a regulation (8).

O ⁶-alkylguanine-DNA alkyltransferase

Another protein involved in DDR, and whose levels have been very recently demonstrated to be regulated by nitroxidative conditions, is the O ⁶-alkylguanine-DNA alkyltransferase (AGT) (Fig. 8). AGT repairs highly mutagenic and cytotoxic O ⁶-alkylguanines (O ⁶-AG) by transferring the alkyl group from DNA to the enzyme active site cysteine, thus restoring guanine. O ⁶-AG is mispaired by DNA polymerases to thymine during DNA replication; the O ⁶-AG:T mispairs can subsequently result in G:C to A:T mutations and DNA DSBs, with both these having been reported as a potent trigger of cell death (39). Although it was known that mice deficient in AGT were more susceptible to tumorigenesis and to acute mortality from alkylating N-nitroso compounds (37), only recently, it has been found that AGT undergo S-nitrosylation on NO (over)production. Liu's laboratory elegantly demonstrated that, once S-nitrosylated, AGT is rapidly degraded via the proteasome system, the DNA being left unrepaired with the result that mutations are established (Fig. 8) (75, 76).

Conclusions

In this review, we have focused on the possibility of molecules involved in DNA damage repair systems being a part of the orchestra characterizing the apoptotic signaling, and how these proteins could function in possible feedback loops to finely regulate either DNA repair or subsequent cell death. Indeed, we have considered DNA repair proteins that are directly associated to “typical” apoptotic factors and, therefore, reasonably implicated in modulating their activity/function on DNA damage. Two well-characterized examples are DDB2 and Ku: Both play a dual role, by acting as DNA repair proteins and inducing the apoptotic signaling according to the severity of DNA damage. However, recent evidence suggests that specific post-translational modifications can completely change the behavior of some proteins involved in DDR, directing them toward a specific outcome: p53 is an emblematic example in this regard. One study after another have attempted to delineate the pathway(s) linking this type of cellular stress (DNA damage), made of several types of lesions and repair systems, to the signaling network dynamically orchestrating the apoptotic cell response. In recent years, the autophagic response has become a part of this scenario: A transient sub-lethal autophagic function could guarantee survival while the repair system acts on DNA. This may help the cell resist organelle-derived stress and is probably regulated by a fine cross-talk with the repair machinery. It is not by chance that p53, the Cullins, and AMPK are involved, as we discussed, in both pathways.

In the context of cancer studies, the understanding and defining of all these processes is of utmost importance: Modulating a cell's capability to better cope with DNA damage has undoubted potential for both cancer prevention and treatment.

Footnotes

Acknowledgments

The authors are grateful to Dr. G. Filomeni for scientific discussion and suggestions. F. Cecconi is supported by Grants from the Telethon Foundation (S99038TELU/TELC), AIRC (2011), FISM (2009), the Italian Ministry of University and Research (PRIN 2009 and FIRB 2011 funding programs), and the Italian Ministry of Health (Ricerca Finalizzata e Ricerca Corrente).

Abbreviations Used

References

Ames

. Endogenous oxidative DNA damage, aging, and cancer. Free Radic Res Commun, 7:121–128. 1989.

Amsel

, Rathaus

, Kronman

, Cohen

. Regulation of the proapoptotic factor Bax by Ku70-dependent deubiquitylation. Proc Natl Acad Sci U S A, 1051:5117–5122. 2008.

Andrews

, Lehman

, Turchi

. Kinetic analysis of the Ku-DNA binding activity reveals a redox-dependent alteration in protein structure that stimulates dissociation of the Ku-DNA complex. J Biol Chem, 281:13596–13603. 2006.

Batchelor

, Loewer

, Lahav

. The ups and downs of p53: understanding protein dynamics in single cells. Nat Rev Cancer, 9:371–377. 2009.

Batchelor

, Loewer

, Mock

, Lahav

. Stimulus-dependent dynamics of p53 in single cells. Mol Syst Biol, 7:488. 2011.

Batchelor

, Mock

, Bhan

, Loewer

, Lahav

. Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage. Mol Cell, 30:277–289. 2008.

Behrends

, Sowa

, Gygi

, Harper

. Network organization of the human autophagy system. Nature, 466:68–76. 2010.

Bennett

, Neher

, Shatilla

, Turchi

. Molecular analysis of Ku redox regulation. BMC Mol Biol, 10:86. 2009.

Bohgaki

, Bohgaki

, Hakem

. DNA double-strand break signaling and human disorders. Genome Integrity, 1:15. 2010.

10.

Branzei

, Foiani

. Regulation of DNA repair throughout the cell cycle. Nat Rev Mol Cell Biol, 9:297–308. 2008.

11.

Budanov

, Karin

. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell, 134:451–460. 2008.

12.

Burma

, Chen

, Murphy

, Kurimasa

, Chen

. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem, 276:42462–42467. 2001.

13.

Cadelcott

. XRCC1 and DNA strand break repair. DNA Repair, 2:955–969. 2003.

14.

Cadet

, Delatour

, Douki

, Gasparutto

, Pouget

, Ravanat

, Sauvaigo

. Hydroxyl radicals and DNA base damage. Mutat Res, 424:9–21. 1999.

15.

Canman

, Lim

, Cimprich

, Taya

, Tamai

, Sakaguchi

, Appella

, Kastan

, Siciliano

. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science, 281:1677–1679. 1998.

16.

Cardaci

, Filomeni

, Ciriolo

. Redox implications of AMPK-mediated signal transduction beyond energetic clues. J Cell Sci, 125:2115–2125. 2012.

17.

Carney

, Maser

, Olivares

, Davis

, Le Beau

, Yates

3rd , Hays

, Morgan

, Petrini

. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell, 93:477–486. 1998.

18.

Cerutti

. Oxy-radicals and cancer. Lancet, 344:862–863. 1994.

19.

Chehab

, Malikzay

, Appel

, Halazonetis

. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev, 14:278–288. 2000.

20.

Chen

, Wang

, Yang

, Huang

, Kulp

, Yang

, Lu

, Matsuyama

, Chen

. Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation. Cancer Res, 67:5318–5327. 2007.

21.

Ciccia

, Elledge

. The DNA damage response: making it safe to play with knives. Mol Cell, 40:179–204. 2010.

22.

Cohen

, Lavu

, Bitterman

, Hekkin

, Imahiyerobo

, Miller

, Frye

, Ploegh

, Kessler

, Sinclair

. Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol Cell, 13:627–638. 2004.

23.

Crighton

, Wilkinson

, O'Prey

, Syed

, Smith

, Harrison

, Gasco

, Garrone

, Crook

, Ryan

. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell, 126:121–134. 2006.

24.

Dai

, Grant

. New insights into checkpoint kinase 1 in the DNA damage response signaling network. Clin Cancer Res, 16:376–383. 2010.

25.

De Zio

, Bordi

, Cecconi

. Oxidative DNA damage in neurons: implication of Ku in neuronal homeostasis and survival. Int J Cell Biol, 2012:752420. 2012.

26.

De Zio

, Bordi

, Tino

, Lanzuolo

, Ferraro

, Mora

, Ciccosanti

, Fimia

, Orlando

, Cecconi

. The DNA repair complex Ku70/86 modulates Apaf1 expression upon DNA damage. Cell Death Differ, 18:516–527. 2011.

27.

Di Giacomo

, Rizza

, Montagna

, Filomeni

. Established principles and emerging concepts on the interplay between mitochondrial physiology and S-(de)nitrosylation: implications in cancer and neurodegenerations. Int J Cell Biol, 2012:361872. 2012.

28.

Fell

, Schild-Poulter

. Ku regulates signaling to DNA damage response pathways through the Ku70 von Willebrand Domain. Mol Cell Biol, 32:76–87. 2012.

29.

Feng

, Hu

, de Stanchina

, Teresky

, Jin

, Lowe

, Levine

. The regulation of AMPKbeta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res, 67:3043–3053. 2007.

30.

Fousteri

, Mullenders

. Transcription-coupled nucleotide excision repair in mammalian cells: molecular mechanisms and biological effects. Cell Res, 18:73–84. 2008.

31.

Gao

, Shen

, Shang

, Wang

. Upregulation of human autophagy-initiation kinase ULK1 by tumor suppressor p53 contributes to DNA-damage induced cell death. Cell Death Differ, 18:1598–1607. 2011.

32.

Green

, Kroemer

. Cytoplasmic functions of the tumour suppressor p53. Nature, 458:1127–1130. 2009.

33.

Hamstra

, Bhojani

, Griffin

, Laxman

, Ross

, Rehemtulla

. Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging. Cancer Res, 66:7482–7489. 2006.

34.

Heyer

W-D

, Ehmsen

, Liu

. Regulation of homologous recombination in eukaryotes. Ann Rev Genet, 44:113–139. 2010.

35.

Hurley

, Bunz

. ATM and ATR, components of an integrated circuit. Cell Cycle, 6:414–417. 2007.

36.

Iijimaa

, Muranakaa

, Kobayashib

, Sakamotob

, Komatsub

, Matsuurac

, Kubotad

, Tauchia

. NBS1 regulates a novel apoptotic pathway through Bax activation. DNA Repair, 7:1705–1716. 2008.

37.

Iwakuma

, Sakumi

, Nakatsuru

, Kawate

, Igarashi

, Shiraishi

, Tsuzuki

, Ishikawa

, Sekiguchi

. High incidence of nitrosamine-induced tumorigenesis in mice lacking DNA repair methyltransferase. Carcinogenesis, 18:1631–1635. 1997.

38.

Jiricny

. The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol, 7:335–346. 2006.

39.

Kaina

, Christmann

, Naumann

, Roos

. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair, 6:1079–1099. 2007.

40.

Kamer

, Sarig

, Zaltsman

, Niv

, Oberkovitz

, Regev

, Haimovich

, Lerenthal

, Marcellus

, Gross

. Proapoptotic BID is an ATM effector in the DNA-damage response. Cell, 122:593–603. 2005.

41.

Kerr

, Holohan

, McLaughlin

, Majkut

, Dolan

, Redmond

, Riley

, McLaughlin

, Stasik

, Crudden

, Van Schaeybroeck

, Fenning

, O'Connor

, Kiely

, Sgobba

, Haigh

, Johnston

, Longley

. Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis. Cell Death Differ, 19:1317–1327.

42.

Kinner

, Wu

, Staudt

, Iliakis

. Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucl Acid Res, 36:5678–5694. 2008.

43.

Lahav

, Rosenfeld

, Sigal

, Geva-Zatorsky

, Levine

, Elowitz

, Alon

. Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat Genet, 36:147–150. 2004.

44.

Lieber

. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Ann Rev Biochem, 79:181–211. 2010.

45.

Lim

, Fujikane

, Sano

, Sakagami

, Nakatsu

, Tsuzuki

, Sekiguchi

, Hidaka

. Activation of AMP-activated protein kinase by MAPO1 and FLCN induces apoptosis triggered by alkylated base mismatch in DNA. DNA Repair, 11:259–266. 2012.

46.

Liu

, Naegele

, Lin

. The DNA-PK catalytic sununit regulates Bax-mediated excitotoxic cell death by Ku70 phosphorylation. Brain Res, 1296:164–175. 2009.

47.

Liu

, Fang

, Shao

, Lindsey-Boltz

, Sancar

, Modrich

. Interactions of human mismatch repair proteins MutSα and MutLα with proteins of the ATR-Chk1 pathway. J Biol Chem, 285:5974–5982. 2010.

48.

Ljungman

, Zhang

. Blockage of RNA polymerase as a possible trigger for u.v. light induced apoptosis. Oncogene, 13:823–831. 1996.

49.

Loewer

, Batchelor

, Gaglia

, Lahav

. Basal dynamics of p53 reveal transcriptionally attenuated pulses in cycling cells. Cell, 142:89–100. 2010.

50.

Maiuri

, Galluzzi

, Morselli

, Kepp

, Malik

, Kroemer

. Autophagy regulation by p53. Curr Opin Cell Biol, 22:181–185. 2010.

51.

Mao

, Bozzella

, Seluanov

, Gorbunova

. DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells. Cell Cycle, 7:2902–2906. 2008.

52.

Marinovic-Terzic

, Yoshioka-Yamashita

, Shimodaira

, Avdievich

, Hunton

, Kolodner

, Edelmann

, Wang

JYJ

. Apoptotic function of human PMS2 compromised by the nonsynonymous single-nucleotide polymorphic variant R20Q. Proc Natl Acad Sci U S A, 105:13993–13998. 2008.

53.

Myers

, Gagou

, Zuazua-Villar

, Rodriguez

, Meuth

. ATR and Chk1 suppress a caspase-3-dependent apoptotic response following DNA replication stress. PLoS Genet, 5:e1000324. 2009.

54.

Nam

, Cortez

. ATR signaling: more than meeting at the fork. Biochem J, 436:527–536. 2011.

55.

Nouspikel

. Nucleotide excision repair and neurological diseases. DNA Repair, 7:1155–1167. 2008.

56.

Ozaki

, Nakagawara

. p73, a sophisticated p53 family member in the cancer world. Cancer Sci, 96:729–737. 2005.

57.

Purvis

, Karhohs

, Mock

, Batchelor

, Loewer

, Lahav

. p53 dynamics control cell fate. Science, 336:1440–1444. 2012.

58.

Quiros

, Roos

, Kaina

. Processing of O6-methylguanine into DNA double-strand breaks requires two rounds of replication whereas apoptosis is also induced in subsequent cell cycles. Cell Cycle, 9:168–178. 2010.

59.

Reinhardt

, Schumacher

. The p53 network: cellular and systemic DNA damage responses in aging and cancer. Trends Genet, 28:128–136. 2012.

60.

Roos

, Kaina

. DNA damage-induced apoptosis: from specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett, 2012[Epub ahead of print]DOI:10.1016/j.canlet.2012.01.007.

61.

Scotcher

, Clarke

, Weidt

, Mackay

, Hupp

, Sadler

, Langridge-Smith

. Identification of two reactive cysteine residues in the tumor suppressor protein p53 using top-down FTICR mass spectrometry. J Am Soc Mass Spectr, 22:888–897. 2011.

62.

Shieh

, Ahn

, Tamai

, Taya

, Prives

. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev, 14:289–300. 2000.

63.

Shimodaira

, Yoshioka-Yamashita

, Kolodner

R-D

, Wang

J-Y

. Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. Proc Natl Acad Sci U S A, 100:2420–2425. 2003.

64.

Sidi

, Sanda

, Kennedy

, Hagen

, Jette

, Hoffmans

, Pascual

, Imamura

, Kishi

, Amatruda

, Kanki

, Green

, D'Andrea

, Look

. Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3. Cell, 133:864–877. 2008.

65.

Stiff

, O'Driscoll

, Rief

, Iwabuchi

, Löbrich

, Jeggo

. ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res, 64:2390–2396. 2004.

66.

Stoyanova

, Roy

, Kopanja

, Bagchi

, Raychaudhuri

. DDB2 decides cell fate following DNA damage. Proc Natl Acad Sci U S A, 106:10690–10695. 2009.

67.

Stoyanova

, Roy

, Kopanja

, Raychaudhuri

, Bagchi

. DDB2 (damaged-DNA binding protein 2) in nucleotide excision repair and DNA damage response. Cell Cycle, 8:4067–4071. 2009.

68.

Stracker

, Morales

, Couto

, Hussein

, Petrini

. The carboxy terminus of NBS1 is required for induction of apoptosis by the MRE11 complex. Nature, 447:218–221. 2007.

69.

Subramanian

, Opipari

Jr , Bian

, Castle

, Kwok

. Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci U S A, 102:4842–4847. 2005.

70.

Sun

, Vinci

, Makmura

, Han

, Tran

, Nguyen

, Hamann

, Grazziani

, Sheppard

, Gutova

, Zhou

, Thomas

, Momand

. Formation of disulfide bond in p53 correlates with inhibition of DNA binding and tetramerization. Antioxid Redox Signal, 5:655–665. 2003.

71.

Symington

, Gautier

. Double-strand break end resection and repair pathway choice. Ann Rev Genet, 45:247–271. 2011.

72.

Velu

, Niture

, Doneanu

, Pattabiraman

, Srivenugopal

. Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress. Biochemistry, 46:7765–7780. 2007.

73.

Wang

JYJ

, Edelmann

. Mismatch repair proteins as sensors of alkylation DNA damage. Cancer Cell, 9:417–418. 2006.

74.

Wei

, Wu

, Vega

, Chiu

, Ng

, Zhang

, Shahab

, Yong

, Fu

, Weng

, Liu

, Zhao

, Chew

, Lee

, Kuznetsov

, Sung

, Miller

, Lim

, Liu

, Yu

, Ng

, Ruan

. A global map of p53 transcription-factor binding sites in the human genome. Cell, 124:207–219. 2006.

75.

Wei

, Li

, Hanes

, Kakar

, Chen

, Liu

. S-nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesis. Sci Transl Med, 2:19ra13. 2010.

76.

Wei

, Yang

, Tang

, Liu

. Targeted deletion of GSNOR in hepatocytes of mice causes nitrosative inactivation of O6-alkylguanine-DNA alkyltransferase and increased sensitivity to genotoxic diethylnitrosamine. Carcinogenesis, 32:973–977. 2011.

77.

Wilson

, Bohr

. The mechanics of base excision repair, and its relationship to aging and disease. DNA Repair, 6:544–559. 2007.

78.

Wiseman

, Halliwell

. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J, 313:17–29. 1996.

79.

Wyman

, Kanaar

. DNA double-strand break repair: all's well that ends well. Ann Rev Genet, 40:363–383. 2006.

80.

Yoshida

, Miki

. The cell death machinery governed by the p53 tumor suppressor in response to DNA damage. Cancer Sci, 101:831–835. 2010.

81.

Yoshioka

, Yoshioka

, Hsieh

. ATR kinase activation mediated by MutSα and MutLα in response to cytotoxic O6-methylguanine adducts. Mol Cell, 22:501–510. 2006.

82.

Yusuf

, Chuang

, Bhat

, Srivenugopal

. Cys-141 glutathionylation of human p53: studies using specific polyclonal antibodies in cancer samples and cell lines. Free Radic Biol Med, 49:908–917. 2010.

83.

Zhang

, Brazhnik

, Tyson

. Exploring mechanisms of the DNA-damage response p53 pulses and their possible relevance to apoptosis. Cell Cycle, 6:85–94. 2007.

New Insights into the Link Between DNA Damage and Apoptosis

Abstract

Introduction

DSBR: The p53 Signaling Network and Apoptotic Functions of Repair Proteins

p53 at the crossroad between DNA damage and apoptosis

Ku

Nijmegen breakage syndrome 1

MMR: Direct or Indirect Correlation to the Apoptotic Signaling?

When MMR is “futile”

MMR proteins as signaling molecules in DDR

NER: When a Repair Protein Functions Twice

The dual role of DDB2

Base Excision and SSBR: Chk1 Opposite Effects on Apoptosis

The ATR/Chk1 signaling pathway

Redox Implications in DNA Damage

Direct oxidative damage

Redox-mediated inhibition of DDR proteins

p53

Ku

O 6-alkylguanine-DNA alkyltransferase

Conclusions

Footnotes

Acknowledgments

Abbreviations Used

References

O ⁶-alkylguanine-DNA alkyltransferase